CAM
Concorde Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,782
| Closed | -$535K | – | 174 |
|
|
2021
Q3 | $535K | Buy |
4,782
+3,267
| +216% | +$366K | 0.31% | 109 |
|
|
2021
Q2 | $245K | Sell |
1,515
-1,330
| -47% | -$215K | 0.14% | 160 |
|
|
2021
Q1 | $346K | Sell |
2,845
-11,867
| -81% | -$1.44M | 0.2% | 127 |
|
|
2020
Q4 | $2.25M | Buy |
14,712
+4,791
| +48% | +$734K | 1.25% | 22 |
|
|
2020
Q3 | $830K | Buy |
+9,921
| New | +$830K | 0.47% | 65 |
|